Home - Products - Others - Other Targets - (1-(10)E,4-Z)-6α,9α,15-Trihydroxy-8β-(tigloyloxy)-14-oxogermacra-1(10),4,11(13)-triene-12-oic acid-12,6-lactone

(1-(10)E,4-Z)-6α,9α,15-Trihydroxy-8β-(tigloyloxy)-14-oxogermacra-1(10),4,11(13)-triene-12-oic acid-12,6-lactone

CAS No. 2382907-32-4

(1-(10)E,4-Z)-6α,9α,15-Trihydroxy-8β-(tigloyloxy)-14-oxogermacra-1(10),4,11(13)-triene-12-oic acid-12,6-lactone( ——— )

Catalog No. M38383 CAS No. 2382907-32-4

(2E)-Leocarpinolide F (Compound 20), a germacrane-type sesquiterpenoid, can be isolated from Sigesbeckia orientalis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    (1-(10)E,4-Z)-6α,9α,15-Trihydroxy-8β-(tigloyloxy)-14-oxogermacra-1(10),4,11(13)-triene-12-oic acid-12,6-lactone
  • Note
    Research use only, not for human use.
  • Brief Description
    (2E)-Leocarpinolide F (Compound 20), a germacrane-type sesquiterpenoid, can be isolated from Sigesbeckia orientalis.
  • Description
    (2E)-Leocarpinolide F (Compound 20), a germacrane-type sesquiterpenoid, can be isolated from Sigesbeckia orientalis.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    2382907-32-4
  • Formula Weight
    376.4
  • Molecular Formula
    C20H24O7
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Liu N, et al. Germacrane-type sesquiterpenoids with cytotoxic activity from Sigesbeckia orientalis. Bioorg Chem. 2019 Nov;92:103196.?
molnova catalog
related products
  • TIC10

    TIC10 inactivates Akt and ERK to induce TRAIL through Foxo3a, possesses superior drug properties: delivery across the blood-brain barrier, superior stability and improved pharmacokinetics. Phase 1/2.

  • Cyclovirobuxin D

    Extracted from Buxus microphylla.

  • Defensin HNP-2 (huma...

    Defensin HNP-2 human is an endogenous antibiotic peptide and monocyte chemotactic peptide produced by human neutrophils.